MEDEZE Group Offers IPO Filing for 150 Million Shares
MEDEZE Group, a pioneering company in stem cell and immune cell innovation, has submitted an IPO filing to the Office of SEC. The company plans to offer nearly 150 million shares, which will be listed on the Stock Exchange of Thailand.
United States Chamras Sakulpaisarn Rangsun Pranpai Veerapol Khemarangsan Rangsun Parnpai Junichi Masuyama
Source: bangkokpost.com